Podcast

Dr Javed Butler: Vericiguat Guidelines

Dr. Javed Butler discusses the Class IIb recommendation for vericiguat in the ESC and ACC heart failure guidelines, highlighting the complexities behind guideline development. He explains how vericiguat's classification reflects the evolving understanding of worsening heart failure as a distinct entity, the limited trial data, and conservative decision-making by guideline committees. Dr. Butler emphasizes that the recommendation is not a downgrade of the therapy's value but rather a reflection of current evidence.

Our speakers
  • MD, MPH, MBA, Baylor Scott and White Health.

    Dr. Javed Butler is a prominent figure in cardiovascular medicine, especially known for his work on heart failure. Based in Dallas, Texas, he holds leadership positions at Baylor Scott & White, including the Maxwell A. and Gayle H. Clampitt Endowed Chair, president, and chief research executive at the Research Institute, and senior vice president at the Health system. His expertise is recognized by his fellowships in several prestigious organizations, such as the Heart Failure Society of America, the European Society of Cardiology, the American College of Cardiology, and the American Heart Association.

Related content